API Development & Manufacturing, Peptides, Large-Scale Chromatography
Acquired from Novartis in 2022, this 111-acre Ringaskiddy campus (operating since 1994) is one of Sterling Pharma Solutions' largest global API manufacturing sites, led by EVP & Site Head Maeve Byrne. Specializes in peptide manufacturing and large-scale chromatography alongside general API development and manufacturing.